266 related articles for article (PubMed ID: 23118288)
1. Psoriatic arthritis and psoriasis projects in Italy: a report from the GRAPPA 2011 annual meeting.
Cauli A; Lubrano E; Scarpa R; Olivieri I
J Rheumatol; 2012 Nov; 39(11):2201-3. PubMed ID: 23118288
[TBL] [Abstract][Full Text] [Related]
2. Prologue: 2011 Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Gladman DD
J Rheumatol; 2012 Nov; 39(11):2181-3. PubMed ID: 23118282
[TBL] [Abstract][Full Text] [Related]
3. Prologue: 2012 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Mease PJ; Boehncke WH; Gladman DD
J Rheumatol; 2013 Aug; 40(8):1407-9. PubMed ID: 23908533
[TBL] [Abstract][Full Text] [Related]
4. GRAPPA Trainees Symposium 2011: a report from the GRAPPA 2011 annual meeting.
Ash Z; Ritchlin CT
J Rheumatol; 2012 Nov; 39(11):2184-8. PubMed ID: 23118283
[TBL] [Abstract][Full Text] [Related]
5. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept.
Lubrano E; Spadaro A; Marchesoni A; Olivieri I; Scarpa R; D'Angelo S; Salvarani C; Mathieu A; Cauli A; Ferrara N; Helliwell P
Clin Exp Rheumatol; 2011; 29(1):80-4. PubMed ID: 21345296
[TBL] [Abstract][Full Text] [Related]
7. Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
Mease PJ; Kivitz AJ; Burch FX; Siegel EL; Cohen SB; Ory P; Salonen D; Rubenstein J; Sharp JT; Tsuji W
Arthritis Rheum; 2004 Jul; 50(7):2264-72. PubMed ID: 15248226
[TBL] [Abstract][Full Text] [Related]
8. Cardiometabolic profile, clinical features, quality of life and treatment outcomes in patients with moderate-to-severe psoriasis and psoriatic arthritis.
Puig L; Strohal R; Husni ME; Tsai TF; Noppakun N; Szumski A; Yang S; Robertson D; Boggs R; Koenig AS
J Dermatolog Treat; 2015 Feb; 26(1):7-15. PubMed ID: 24283931
[TBL] [Abstract][Full Text] [Related]
9. Etanercept: an evolving role in psoriasis and psoriatic arthritis.
Prodanovich S; Ricotti C; Glick BP; Inverardi L; Leonardi CL; Kerdel F
Am J Clin Dermatol; 2010; 11 Suppl 1():3-9. PubMed ID: 20586498
[TBL] [Abstract][Full Text] [Related]
10. Prologue: 2013 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Boehncke WH; Gladman DD
J Rheumatol; 2014 Jun; 41(6):1194-6. PubMed ID: 24882850
[TBL] [Abstract][Full Text] [Related]
11. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Mease PJ; Goffe BS; Metz J; VanderStoep A; Finck B; Burge DJ
Lancet; 2000 Jul; 356(9227):385-90. PubMed ID: 10972371
[TBL] [Abstract][Full Text] [Related]
12. Combination of skin, joint and quality of life outcomes with etanercept in psoriasis and psoriatic arthritis in the PRESTA trial.
Prinz JC; Fitzgerald O; Boggs RI; Foehl J; Robertson D; Pedersen R; Molta CT; Freundlich B
J Eur Acad Dermatol Venereol; 2011 May; 25(5):559-64. PubMed ID: 20840349
[TBL] [Abstract][Full Text] [Related]
13. Early treatment of psoriatic arthritis is associated with improved patient-reported outcomes: findings from the etanercept PRESTA trial.
Kirkham B; de Vlam K; Li W; Boggs R; Mallbris L; Nab HW; Tarallo M
Clin Exp Rheumatol; 2015; 33(1):11-9. PubMed ID: 25535650
[TBL] [Abstract][Full Text] [Related]
14. Self-reported health outcomes in patients with psoriasis and psoriatic arthritis randomized to two etanercept regimens.
Gniadecki R; Robertson D; Molta CT; Freundlich B; Pedersen R; Li W; Boggs R; Zbrozek AS
J Eur Acad Dermatol Venereol; 2012 Nov; 26(11):1436-43. PubMed ID: 22035157
[TBL] [Abstract][Full Text] [Related]
15. Potential of tumor necrosis factor inhibitors in psoriasis and psoriatic arthritis.
Krueger G; Callis K
Arch Dermatol; 2004 Feb; 140(2):218-25. PubMed ID: 14967799
[TBL] [Abstract][Full Text] [Related]
16. Nail Enthesis Ultrasound in Psoriasis and Psoriatic Arthritis: A Report from the 2016 GRAPPA Annual Meeting.
Cunha JS; Qureshi AA; Reginato AM
J Rheumatol; 2017 May; 44(5):688-690. PubMed ID: 28461527
[TBL] [Abstract][Full Text] [Related]
17. Prologue: 2018 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Callis Duffin K; Gladman DD; Gottlieb AB; Goel N
J Rheumatol Suppl; 2019 Jun; 95():1-3. PubMed ID: 31154397
[TBL] [Abstract][Full Text] [Related]
18. Prologue: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) 2022 Annual Meeting.
Gottlieb AB; Armstrong AW; FitzGerald O; Gladman DD
J Rheumatol; 2023 Nov; 50(Suppl 2):1-3. PubMed ID: 37419627
[TBL] [Abstract][Full Text] [Related]
19. Follow-up of psoriatic arthritis mutilans patients treated with anti-TNF-alpha therapy.
Pomerantz RG; Mody E; Husni ME; Qureshi AA
J Drugs Dermatol; 2009 Apr; 8(4):406-12. PubMed ID: 19363860
[TBL] [Abstract][Full Text] [Related]
20. Prologue: 2017 Annual Meeting of the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA).
Helliwell PS; Gladman DD; Gottlieb AB
J Rheumatol Suppl; 2018 Jun; 94():1-3. PubMed ID: 29858345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
